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Introduction. Endovascular repair (EVAR) of acute symptomatic and ruptured abdominal aortic aneurysm (rAAA) can be
difficult without a large stock of suitable graft sizes. We report a prospective European multicentre study of a modular
aortouniiliac stent-graft.
Patients and methods. Seven centres, with elective EVAR experience, participated in the study. Sixty-five patients were
enrolled from September 2002 e April 2005. Some 45 patients had rAAA and 20 were acutely symptomatic. Their median
age was 74 (69e80.3) years, 49 (75%) were men. From a choice of 4 body and 4 limb sizes, stent-grafts were deployed
under local or general anaesthesia.
Results. The endovascular delivery system was introduced and the aneurysm excluded from the circulation in a median of
40 (30e60) minutes from the first incision.
The median operative duration was 150 (120e190) mins, blood loss 300 ml (200e800). 33 (51%) operations were
performed by a vascular surgeon alone.
There were a total of 4 (6%) peri-operative re-interventions, endovascular (n¼ 1), open (n¼ 2) and thrombectomy
(n¼ 1). The peri-operative mortality in the rupture group was 40% and 10% in the symptomatic group.
Conclusions. Aortouniiliac stent-grafts provide rapid exclusion of rAAA. Suitably trained surgeons can do the operation
without a radiologist’s support. The mortality rate from rAAA treated with EVAR remains high.
 2007 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
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Several hospitals have published their experience
with endovascular repair (EVAR) of ruptured abdom-
inal aortic aneurysms (rAAA). Despite encouraging
results, the proportion of patients with rAAA being
treated by EVAR remains low.1 This may be because
of logistical problems including the availability of an
experienced endovascular team and a sufficient stock
of suitable grafts.
To enable EVAR for rAAA, it has been suggested
that endovascular stent-grafts must be immediately
available in a wide range of sizes. This would require
a large stock of bifurcated stent-grafts and may not,
for financial and storage reasons be possible in most
vascular units.
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a See acknowledgements for European BiFab Study Collaborators.1078–5884/000291+ 08 $32.00/0  2007 Published by Elsevier Ltd oA stent-graft designed for rAAA should achieve
rapid haemorrhage control and, given the emergent
nature of the disease, be straightforward to deploy,
and require a minimum of endovascular expertise.
The objective of this study was to determine the
safety and performance of a modular aortouniiliac
endovascular stent-graft, (Cook Europe, Bjaereskov,
Denmark), for the treatment of acute symptomatic
and ruptured infra-renal abdominal aortic aneurysms.
Methods
The study was an open multicentre study, with seven
participatingEuropeancentres. (see acknowledgments).
All of the participants were experienced with the
Zenith aortic stent-graft for elective EVAR. They re-
ceived training in deployment of the experimental
system.
Patient enrolment started in September 2002 and
continued until May 2005. Patients aged more than 50
years, with an acute symptomatic (abdominal or backn behalf of European Society for Vascular Surgery.
292 R. J. Hinchliffe et al.pain of less than 48 hours duration) or thosewith a rup-
tured AAA confirmed by contrast enhanced computed
tomographic angiography (CTA) were eligible for
enrolment. Patients had to meet all the inclusion and
exclusion criteria (Fig. 1). Each centre received local
ethics committee approval. Where possible, patients
provided written or verbal consent for study entry.
The participating vascular units were provided
with a total of four proximal stent-graft components
(22, 26, 30 and 34 mm diameter), four distal stent-graft
components (12, 16, 20, 24 mm distal diameter) and
two ‘over the wire’ occluding plugs (16, 24 mm dia-
meter). The main body and iliac limb lengths werea standard 130 mm and 100 mm long respectively.
The components had a 12 mm junction so that the dis-
tal limb could be inserted into the proximal body. The
length of the deployed graft could therefore be varied
between 130 mm and 205 mm. If patients required
a longer graft then a 12 mm diameter stent could be
inserted between the two components.
All patients had pre-operative spiral CTA. The
operations were performed by a vascular surgeon or
interventional radiologist (or both) depending upon
local experience. The type of anaesthesia (local or
general anaesthetic) was left at the discretion of the
operating surgeon. The main body of the stent-graftInclusion criteria 
The patients must have met the following criteria before entering the study:
1. The patient is 50 years or older. 
2. The patient has a Ruptured Aneurysm (retroperitoneal haematoma +/- extravasation of contrast on contrast CT)  or an Acute Symptomatic
Aneurysm (<48 hours) of the infrarenal, abdominal aorta.
3. Anatomical criteria for Acute Symptomatic Aneurysm
a. Location of lesion:
I. Infrarenal segment of the abdominal aorta
II. Length from the lowest renal artery to the aneurysm sac >10 mm
b. Aneurysm size:
I. Length of proximal, aneurysm neck/fixation site >10 mm
II. Aneurysm neck <32 mm diameter
III. External iliac artery diameter  ≥7 mm
4. Anatomical criteria for ruptured aneurysm:
If the surgeon estimates that there is a good chance of aneurysm exclusion.
5. Patient's informed consent is obtained. A witnessed verbal consent is permissible for ruptured cases, whereas  written consent is required for acute, 
symptomatic cases.
Exclusion criteria
Exclusion of patients was always left to the discretion and judgment of the investigators of the participating centres. If there is a questionable
contraindication, the Principal Investigator has to be consulted.   
In the treatment of patients with ruptured aneurysms, the  morphological assessment of suitability is left to the discretion of the operating surgeon
(given the broad guidelines).   
1. Anatomical criteria, from CTA scan: 
a. Location of lesion: aneurysm less than 10 mm below renal arteries
b. Aneurysm neck diameter  ≥32 mm
c. External iliac artery diameter <7 mm
2. The patient is suffering from an acute life-threatening illness other than the aortic disease to be treated with the Zenith® Endovascular Graft.   
3. Pregnancy 
4. Anaphylactic reaction to contrast media 
5. Allergy to stainless steel or polyester
6. Inability to obtain informed consent
Fig. 1. Study entry criteria.
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sion (ipsilateral iliac artery), which was ‘tromboned’
inside the main body according to the length required.
The stent-grafts were oversized by 4e6 mm in the
proximal aortic neck and 2e3 mm in the iliac artery.
After deployment of the aortouniiliac stent-graft an
occluding plug was deployed in the contralateral
common iliac artery. If the contra-lateral common iliac
had a diameter greater than 22 mm then a larger
occluding device was used (Endomed, Endomed
Inc, Phoenix, AZ). The procedure was completed
with a femoro-femoral bypass graft to restore flow
to the contra-lateral femoral artery. At the end of the
procedure all patients had intra-operative ‘completion
angiography’ to determine whether the aneurysm had
been excluded.
A detailed account of the deployment sequence of
the Zenith stent-graft is given elsewhere.2 One of the
perceived advantages of the aortouniiliac device was
the absence of the need for cannulation of a short
limb of the graft.
The efficacy of the experimental stent-graft was
determined by patient outcome at 1 month, 3 months,
6 months and 12 months. The primary endpoint was
patient survival at 1 month. Patients were followed
up with clinical examination and CTA. An indepen-
dent data monitor assessed the validity of data
received from each hospital.
Outcome data were divided into patients treated
for symptomatic AAA and those treated for rAAA.
Patients
A total of 65 patients were enrolled in the study be-
tween September 2002 and May 2005 (Nottingham
(n¼ 33); Truro (n¼ 5); Bournemouth (n¼ 5); Ostrava-
Vitkovice (n¼ 11); Stockholm (n¼ 2); San Sebastian
(n¼ 7); Plzen (n¼ 2)). Procedures were performed by
a team of vascular surgeon and interventional radiolo-
gist in 32 (49%) patients. The remainder were treated
by a vascular surgeon alone.
Some 45 patients (69%) were treated for ruptured
AAA and 20 (31%) for acute symptomatic AAA. The
mean age of patients in the ruptured group was 76.6
(range 60e91) years and 75.5 (67e85) in the symptom-
atic group. Thirty-three (73%) and 16 (80%) were male
in the respective groups. Some five patients (11%) in
the rupture group and eight (40%) in the acute symp-
tomatic group had previously had open (n¼ 4) or
endovascular repair (n¼ 9) of their abdominal aortic
aneurysm.
The ASA distribution is given in Table 1. The Soci-
ety for Vascular Surgery/International Society for
Cardiovascular Surgery (SVS/ISCVS) risk-factor scorewas also used.3 The median SVS-ISCV risk score was 4
(2e7) in the rupture group and 7 (4e10) in the acute
symptomatic group. Thirty eight percent of patients
in both groups had a history of cardiovascular dis-
ease. Some 21% of patients with ruptured AAA and
23% of acute symptomatic patients had pulmonary
disease.
Pre-operative haematological and biochemical
analyses were similar between groups (Table 2). Rup-
tured aneurysms were larger than their symptomatic
counterparts (Table 3).
The most commonly used main body sizes were the
two largest diameters, 34 mm (n¼ 22) and 30 mm
(n¼ 13) (Table 4). A total of five patients required an
additional 12 mm iliac limb to act as a bridging piece
to meet the required aortoiliac length (ruptured n¼ 3;
symptomatic n¼ 2).
Four patients required body extensions (n¼ 2) or
Palmaz stents (Palmaz P4014 stent, Cordis Endovas-
cular, Warren, NJ, USA) (n¼ 2) to fully exclude the
aneurysm. These are discussed below.
Six (13%) of the ruptured cases were sufficiently
stable to be done under regional anaesthesia (Table 5).
Results
Ruptured AAA
There were no intra-operative deaths. A total of
14 (31%) patients died in the rupture group within
30 days. Some six patients died within 24 hours of
Table 1. ASA distribution of patients
ASA class Rupture n¼ 45 (%) Symptomatic n¼ 20 (%)
I 0 (0) 0 (0)
II 2 (4) 4 (20)
III 6 (13) 9 (45)
IV 22 (49) 5 (25)
V 15 (33) 2 (10)
Table 2. Pre-operative haematological and biochemical analysis
Rupture median
(iq range)
Symptomatic median
(iq range)
WBC (103/mm3) 12.5 (10.7e16.6) 8.7 (7.1e9.8)
Platelets (103/mm3) 166 (128e225) 231 (193e292)
Hematocrit (%) 33.0 (27.0e38.6) 41.0 (38.3e42.4)
Hb (g/dL) 11.0 (9.4e12.5) 13.7 (12.5e14.3)
Prothrombin time (sec) 12.0 (10.5e17.0)x 11.7 (10.9e14.6)k
Partial thromboplastin
time (sec)
31.5 (25.1e45.9)Y 30.5 (28.6e31.7))
Glucose 7.8 (6.6e10.4)* 6.6 (4.5e8.7)y
Urea 7.6 (6.6e10.9) 6.4 (4.5e8.7)
Creatinine 132 (109e176) 110 (94e126)
* Data available in n¼ 19 patients; y n¼ 10; x n¼ 35; k n¼ 15;
Y n¼ 30; ) n¼ 14.
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iliac artery. They had an uncomplicated deployment
of the aortouniiliac graft. Review of the pre-operative
CTA showed that the iliac artery was the site of the
Table 3. Pre-operative aneurysm morphology
Morphology (mm) Rupture
(median,
iq range)
Symptomatic
(median,
iq range)
AAA diameter 85 (72e96) 75 (59e87)
Supra-renal diameter 25 (22e28) 25 (21e26)
Neck length 25 (18e35) 22 (19e30)
Neck diameter 26 (22e28) 24 (21e26)
Renal artery to aortic bifurcation 130 (118e144) 120 (112e130)
Proximal neck to aneurysm angle 40 (30e80)U 72 (54e115)N
Calcification of proximal neck y x
None 16 8
Scattered 15 10
Two-thirds of the circumference 1 0
Circumferential 0 0
Thrombus at proximal neck * k
None 19 5
Scattered 10 8
Two-thirds of the circumference 2 5
Circumferential 0 0
Right common iliac artery diameter 16 (12e21) 16 (12e20)
Left common iliac artery diameter 14 (12e21) 16 (10e20)
Right common iliac artery length 50 (40e57) 59 (53e66)
Left common iliac artery length 50 (40e60) 60 (50e60)
Right external iliac artery diameter 9 (8e10) 10 (9e11)
Left external iliac artery diameter 9 (8e10) 11 (10e12)
U Data available in 17 patients (n¼ 17); N n¼ 11; y n¼ 32;
x n¼ 18; * n¼ 31; k n¼ 18.
Table 4. Stent-graft sizes used
Device used Ruptured (n¼ 45) Symptomatic (n¼ 20)
Zenith Rupture Body*
ZRB e 22 mm 3 0
ZRB e 26 mm 12 5
ZRB e 30 mm 15 8
ZRB e 34 mm 161 6
Zenith Rupture Leg
ZRL e 12 mm 13 4
ZRL e 16 mm 12 3
ZRL e 20 mm 8 7
ZRL e 24 mm 11 5
Iliac PlugY
ZIP e 16 mm 12 9
ZIP e 24 mm 19 8
ESP-20-20y 1 0
Endomed 36 mm 1 0
Endomed 40 mm 0 1
Leg Extension
TFLE-12-88 1 1
TFLE-20-88 1 0
TFLE-18-71 0 1
ELSE-16-55 1 0
1 One ZRB-34 used as extension to create aneurysm seal.
y Previous generation occluder (not an over the wire system).
* Data missing on one patient with symptomatic aneurysm.
Y In one symptomatic patient no occluder was required due to
pre-operative iliac artery occlusion. Data were not available in an-
other symptomatic patient. In the rupture group, one iliac artery
was occluded pre-op and another patient was converted to open
repair. Data were missing in a total of 10 patients.
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the lesion. The iliac artery rupture was not recognised
intra-operatively or on completion angiography
(Table 6).
Two patients suffered bilateral renal artery occlu-
sion. One of these was intentional. The patient was
already on dialysis for chronic renal failure and pre-
sented with rupture. He had unfavourable aneurysm
morphology with a short neck but was offered EVAR
on compassionate grounds. The stent-graft was
placed across both renal artery ostia to seal the aneu-
rysm. The other patient had no further intervention
and was started on haemodialysis.
A total of eight patients had internal iliac artery
occlusion, four of which were in the ruptured group.
None of the occlusions were bilateral. Three were de-
liberate and necessary to adequately seal off blood
flow to the aneurysm.
One patient with rAAA required conversion to
open repair because the stent-graft was pulled into
the aneurysm sac. Another patient with rAAA devel-
oped intra-operative stent-graft thrombosis. Their
operation was converted to an axillo-bifemoral graft.
The causes of death for the other 8 patients who
died following rAAA repair (>24hours but within
Table 5. Intra-operative data
Rupture (%)
median
(iq range)
Symptomatic
(%) median
(iq range)
Anesthesia type
General 30 (67) 12 (60)
Regional 6 (13) 8 (40)
Local 9 (20) 0 (0)
Stent-graft deployment
(minutes)
30 (20e45)Y 50 (30e60) w
Fluoroscopy (minutes) 18 (14e28)U 21 (17e25)

Duration of procedure
(minutes)
150 (120e180) 158 (120e213)
Contrast volume (ml) 150 (133e200) 190 (146e268)
Number requiring blood
products
29 (64) 7 (35)
Blood loss (ml) 425 (200e825)k 200 (100e500)x
Replaced blood volume (ml) 1400 (600e2000)* 600 (400e925)y
Y Data available in n¼ 36 patients; w n¼ 17; U n¼ 22;  n¼ 12;
k recorded in n¼ 32; x recorded in n¼ 17; * In n¼ 20 patients
receiving transfusion (median 600 ml (0e1500) in all rAAA
patients); y In 7 patients receiving transfusion (median 0 ml
(0e400) in all symptomatic patients).
Table 6. Intra-operative complications
Complication Ruptured Symptomatic
Bilateral renal artery occlusion 2 2
Internal iliac artery occlusion 4 4
Stent-graft thrombosis 1 0
Iliac artery rupture 1 0
Stent-graft migration 1 0
295Modular Aortouniiliac Stent-graft for rAAA30 days) were multiple organ failure (MOF) (4), acute
renal failure (2), myocardial infarction (1) and respira-
tory failure (1).
A further four patients died in hospital after 30
days giving a total 30-day and in-hospital mortality
of 40% (18) for the rupture group. Of the four deaths
in hospital after 30 days, one patient died of gastric
cancer on day 92. The cancer presented with gastroin-
testinal bleeding post-operatively. Another patient
died on day 34 as a result of a perforated duodenal
ulcer. A patient died as the result of aspiration pneu-
monia from an enteral feeding tube (day 39). A fourth
patient died on day 62 from chest infection and respi-
ratory failure. He had a history of severe COAD and
exacerbation pre-operatively.
A number of patients had peri-operative adverse
events (Table 7). One patient with a rAAA developed
abdominal compartment syndrome. The most com-
mon systemic complications in those undergoing
rAAA repair were pulmonary (38%) and renal
(36%). The number of peri-operative adverse events
was far higher in those undergoing rAAA repair
(57 versus 6). Some required additional endovascular
and open procedures.
Following rAAA repair there was one type I leak
which was detected 12hours post-operatively when
the patient became haemodynamically unstable. The
patient was taken back to the operating theatre and
had a laparotomy and placement of peri-aortic bands
around the aortic neck. On review, the patient had
placement of an undersized stent-graft. The stent-
graft had been sized using intra-operative calibration
angiography because of a poor quality pre-operative
CT. A 22 mm stent-graft was placed in a 22 mm aortic
neck. Completion angiography had not revealed an
endoleak.
There were 5 type II endoleaks which were left
without intervention.
In the rupture group three patients died after dis-
charge from hospital. One died at 9 weeks from
Table 7. Peri-operative adverse events
Peri-operative Adverse Event Rupture
(n¼ 45)
Symptomatic
(n¼ 20)
Systemic complications
Cardiac 9 1
Cerebral 2 0
Pulmonary 17 0
Renal 16 1
Gastrointestinal 5 1
Haematological 2 0
Other 1 0
Peripheral neurological complications 3 0
Access site complications 2 2
Ischaemic complications 1 1a type A thoracic aortic dissection and another died
of congestive cardiac failure at 6 months. There was
one aneurysm related death, from sepsis (20 weeks).
The source of the sepsis was the aortic pseudoaneur-
ysm that had been treated by EVAR.
During follow-up (post 30-days), Two of the 3 type II
endoleaks in the ruptured group sealed spontaneously.
There were no type I or type III endoleaks detected
during follow up.
There were two open interventions required in the
rAAA group but no endovascular intervention. One
patient required incision and drainage of a groin
abscess (no evidence of graft infection). The patient
who had required EVAR of a ruptured aortic pseu-
doaneurysm needed percutaneous drainage of an
abscess.
Acute symptomatic AAA
In the symptomatic group, the 30-day mortality was
5% (1). This patient died on day 4 from multiple organ
failure. A second patient in this group died in-hospital
from acute renal failure on day 33 giving a 30-day and
in-hospital mortality of 10% (2).
There were two bilateral renal artery occlusions.
One patient underwent mesentero-renal bypass and
another was converted to open repair.
One patient in the symptomatic group required
a thrombectomy for an occluded femoro-femoral
bypass graft.
Two endoleaks were detected in the symptomatic
group. One CTA detected type I endoleak was treated
successfully by placement of a main body extension
piece and Palmaz stent 5 days after the first operation.
There was also one type 2 endoleak which was
observed.
There were two late deaths in the symptomatic
group. One patient died from the complications of
chronic renal failure at 7 months. This patient was
on dialysis prior to EVAR. Another died from oeso-
phageal cancer at 8 months.
In the symptomatic group three patients developed
claudication (one had buttock claudication because of
an internal iliac artery (IIA) occlusion). In the rupture
group one patient had intermittent claudication (both
IIAs were patent), one had a wound abscess, one
patient developed sepsis and three patients developed
neurological complications. One developed an epidu-
ral haematoma following epidural anaesthetic. Of the
other two patients, one had femoral nerve neuralgia
requiring medical treatment and another developed
foot drop (IIA occlusion).
During follow-up there were no open secondary
interventions required in the symptomatic group but
Eur J Vasc Endovasc Surg Vol 34, September 2007
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Two patients received coil embolisation of type II
endoleaks (4 and 5 months post-operatively). Another
patient had angioplasty of an external iliac stenosis
for the treatment of intermittent claudication (11
months).
Discussion
The modular aortouniiliac stent-graft system was pro-
posed for elective EVAR in 1997.4 It was suggested
that a modular aortouniiliac comprising 16 compo-
nents could replace a total of 750 unitary bifurcated
systems. The Nottingham group further developed
this concept.5 Others have adopted a similar stent-
graft system for the management of rAAA.6
This study has demonstrated that an ‘off the shelf’
aortouniiliac stent-graft can be used to repair acute
symptomatic and ruptured AAA. In this multi-centre
European study by seven experienced endovascular
centres the peri-operative mortality rates compared
favourably with those published for conventional
open repair.7 This was a selected study population,
where many patients had been turned down for con-
ventional elective open repair.
One of the limitations of the emergency endovascu-
lar technique is the need for an endovascular team.
Use of an aortouniiliac system reduced the need for
some of the skills required to perform elective
EVAR. Specifically those required to swiftly cannulate
the short limb of a bifurcated graft. Many vascular
units have insufficient radiologists to provide an
emergency endovascular service.8 In this study,
appropriately trained vascular surgeons treated half
of the patients without a radiologist being present
in the operating room. The surgeons had not had
traditional radiology training.
One advantage of the aortouniiliac system may be
the speed of haemorrhage control. Bifurcated systems
require catheterisation of the stent-graft and place-
ment of a contralateral iliac limb before the rAAA
can be excluded from the circulation. This
manoeuvre can take time even in experienced hands.
In this trial it was possible to achieve rapid aneu-
rysm exclusion in the majority of patients. The
median time to exclusion of rAAA was 30 minutes
(Table 5).
However it took 150 (median) minutes to perform
the operation. In a contemporary series from an expe-
rienced centre using bifurcated stent-grafts (Zenith,
Cook) in selected patients with ruptured AAA, the
mean operating time was 110 minutes.9 The
increased time in this study was probably related to
Eur J Vasc Endovasc Surg Vol 34, September 2007the cross-over graft component of the operation.
Other techniques may achieve more rapid aneurysm
control. These include aortic occlusion balloons or
the percutaneous delivery of the stent-graft. Neither
technique was used in this series. Percutaneous place-
ment of an aortouniiliac system is possible but surgi-
cal exposure of the femoral arteries is required to
fashion the femoro-femoral bypass.
In this study the larger diameter main body compo-
nents were used more frequently (30 mm, 34 mm).
This was not a surprising finding as it has already
been demonstrated that large aneurysms usually
have large diameter necks.10 The advantages of an aor-
touniiliac system were exemplified by the two patients
who had ectatic contralateral iliac arteries. If a bifur-
cated system had been used then the device would
have been deployed in the external iliac artery, risking
continued AAA perfusion via a patent internal iliac ar-
tery. In these two patients large occluding plugs were
used (36 mm and 40 mm Endomed, Endomed Inc,
Phoenix, AZ). The durability of these devices has not
been published. Both plugs successfully occluded the
common iliac artery up to one-year follow-up.
The facility for ‘tromboning’ of the aortouniiliac
device made it possible to treat the longer renal artery
to aortic bifurcation distance found in rAAA. The
median renal artery-aortic bifurcation distance in the
ruptured group was 130 mm and common iliac artery
50 mm. Some AAA were so long that five patients
(rAAA, n¼ 3, symptomatic n¼ 2) needed a 12 mm
extension piece to fully exclude the aneurysm.
One stent-graft was not sufficiently oversized in the
aortic neck. This problemwas encountered in a patient
with a poor pre-operative CTA scan and measure-
ments were done using intra-operative calibration
angiography. The resulting endoleak and secondary
open intervention (peri-aortic ligatures) emphasised
the importance of good pre-operative CTA.
There were several complications that resulted
directly from operator error. One stent-graft was de-
ployed too proximally occluding both renal arteries.
Three major complications (2 bilateral renal artery oc-
clusions and one migration) were encountered during
retrieval of the delivery system. It is vital to visualize
the docking procedure of the top cap with the deliv-
ery system. Failure to do so resulted in the graft mi-
grating cranially occluding both renal arteries in two
patients whilst in another the supra-renal stent was
caught during cap retrieval and the whole stent-graft
was dragged into the aneurysm sac. The operating
surgeon did not adequately visualise the latter proce-
dure using fluoroscopy.
The device and operator errors may not have been
surprising because of the emergent nature of surgery
297Modular Aortouniiliac Stent-graft for rAAAand adverse aneurysm morphology. Complications
can occur with open repairs. In one study of open
surgery over a 10-year period, the rate of vascular
complications following rAAA repair was double
that seen during elective repair (17% versus 8%).11
In this study patients were followed up for one
year. Previous studies on open rAAA repair sug-
gested that patients continued to die up to one year
post-operatively from the lingering effects of the rup-
ture and peri-operative physiological insults.11 This
did not appear to be the case in the present study.
Only the patient with an infected pseudoaneurysm
suffered an aneurysm related death after 30 days.
One of the risks of emergency surgery might be
inadequate planning of the graft and subsequently
a high secondary intervention rate. In the rupture
group there were a total of four (9%) (two early, two
late) re-interventions during the follow-up period of
one year. These results are similar to the U.K. EVAR
1 trial.12 In that trial the secondary intervention rate
for elective EVAR was approximately 10% at one
year. This suggests there were no more complications
in the mid-term with patients who had aortouniiliac
EVAR for ruptured AAA when compared with their
elective counterparts.
Despite the endovascular approach there were
a significant number of systemic adverse events in
patients with rAAA, notably pulmonary in 38% (17)
and renal in 36% (16). The incidence of pulmonary
complications is reasonable when compared with
results after open repair of rAAA, however, the inci-
dence of renal complications is similar.13 Although
some of these complications are inevitable in criti-
cally ill patients with rupture, it may be possible to
reduce their incidence by refining the endovascular
technique.
Only one patient developed the abdominal com-
partment syndrome. However, pulmonary complica-
tions were the most common systemic complication
following EVAR. Some authors have demonstrated
the feasibility of repair of ruptured aneurysms using
local anaesthesia and sedation.9 A recent analysis of
the EUROSTAR database of patients undergoing
elective EVAR found no significant difference
(2.2% -v- 1%) in pulmonary complications between
those undergoing general (n¼ 3848) or local anaesthe-
sia (n¼ 310).14 Indeed, it carries some potential draw-
backs including patient discomfort and movement
artefact. The local anaesthetic technique usually
requires a bifurcated stent-graft system. The require-
ment for a femoro-femoral cross-over graft makes
this difficult and consequently it was only possible
to perform EVAR under total local anaesthesia in
nine (14%) cases.In this series there were three (6%) cases of periph-
eral neurological damage, three times the incidence
noted following open repair.13 Buth and colleagues
have demonstrated significant rates of paraplegia
following EVAR of ruptured AAA, particularly
when associated with occlusion of one or both inter-
nal iliac arteries.15
Further work is required to identify those patients
with symptomatic and rAAA who will be best
treated by EVAR compared with open repair. This
study has shown that the modular aortouniiliac
stent-graft will be a useful tool for the vascular
specialist.
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